Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Krzysztof Tomasiewicz and Dorota Zarebska-Michaluk.
Krzysztof Tomasiewicz
Connection Strength
1.797
Dorota Zarebska-Michaluk
  1. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021. Pol Arch Intern Med. 2021 05 25; 131(5):487-496.
    View in: PubMed
    Score: 0.236
  2. Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6. J Clin Med. 2021 Apr 09; 10(8).
    View in: PubMed
    Score: 0.235
  3. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020. Pol Arch Intern Med. 2020 10 29; 130(10):915-918.
    View in: PubMed
    Score: 0.228
  4. Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study. Expert Rev Anti Infect Ther. 2021 01; 19(1):93-100.
    View in: PubMed
    Score: 0.224
  5. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 1 as of June 8, 2020. Pol Arch Intern Med. 2020 06 25; 130(6):557-558.
    View in: PubMed
    Score: 0.222
  6. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020. Pol Arch Intern Med. 2020 04 30; 130(4):352-357.
    View in: PubMed
    Score: 0.219
  7. Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals? J Interferon Cytokine Res. 2018 02; 38(2):93-100.
    View in: PubMed
    Score: 0.188
  8. Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study. Pol Arch Intern Med. 2021 01 29; 131(1):103-110.
    View in: PubMed
    Score: 0.058
  9. Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study. J Clin Med. 2020 Dec 24; 10(1).
    View in: PubMed
    Score: 0.058
  10. Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study. Adv Med Sci. 2017 Sep; 62(2):387-392.
    View in: PubMed
    Score: 0.045
  11. Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clin Exp Hepatol. 2016 Dec; 2(4):138-143.
    View in: PubMed
    Score: 0.043
  12. Prevalence of HCV genotypes in Poland - the EpiTer study. Clin Exp Hepatol. 2016 Dec; 2(4):144-148.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.